Cantabio Pharmaceuticals to Present at 2017 Silicon Valley Bank Healthcare Capital and Connections Summit in Shanghai September 13, 2017
Cantabio announces publication of study on a mechanism by which the DJ-1 protein loses its defensive function in neurodegenerative disease conditions September 11, 2017
Cantabio Announces Publication of Study Results by University of Cambridge researchers in ACS Chemical Neuroscience July 6, 2017
Cantabio Pharmaceuticals to Present Update from Its DJ-1 Protein Targeting Therapeutic Program for the Treatment of Parkinson's Disease at the 13th International Conference on Alzheimer's and Parkinson's Disease March 28, 2017
Cantabio Pharmaceuticals to Present at the 2nd Annual Neuroscience BioPartnering and Investment Forum at the New York Academy of Sciences in New York March 14, 2017
Cantabio Pharmaceuticals to Present Results from Its Tau Protein Targeting Therapeutic Program for the Treatment of Alzheimer's Disease at the 13th International Conference on Alzheimer's and Parkinson's Disease February 14, 2017
Cantabio Pharmaceuticals announces Definitive Funding Agreement of up to $600,000 from Yorkville Advisors Global February 2, 2017